We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+5.47%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$6.89B
AUM Growth
-$226M
Cap. Flow
-$560M
Cap. Flow %
-8.14%
Top 10 Hldgs %
12.13%
Holding
2,170
New
136
Increased
1,113
Reduced
460
Closed
437

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.72M
2
JNJ icon
Johnson & Johnson
JNJ
+$7.46M
3
NVS icon
Novartis
NVS
+$6.93M
4
PG icon
Procter & Gamble
PG
+$6.45M
5
T icon
AT&T
T
+$5.65M

Sector Composition

Rank Sector Weight
1 Financials 16.45%
2 Technology 13.56%
3 Healthcare 13.52%
4 Energy 9.92%
5 Industrials 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MO icon
51
Altria Group
MO
$125B
$25.4M 0.37%
606,407
+2,903
+0.5% +$117K
C icon
52
Citigroup
C
$213B
$25.2M 0.37%
535,608
-19,646
-4% -$934K
WBK
53
DELISTED
Westpac Banking Corporation
WBK
$24.7M 0.36%
768,631
+71,729
+10% +$2.32M
V icon
54
Visa
V
$701B
$23.8M 0.35%
451,496
-23,732
-5% -$1.24M
AMGN icon
55
Amgen
AMGN
$209B
$23.7M 0.34%
200,166
-10,299
-5% -$1.19M
SAN icon
56
Banco Santander
SAN
$191B
$23.2M 0.34%
2,455,395
+277,847
+13% +$2.55M
SNY icon
57
Sanofi
SNY
$107B
$22.9M 0.33%
430,639
+83,454
+24% +$4.43M
ADP icon
58
Automatic Data Processing
ADP
$109B
$22.7M 0.33%
325,937
+5,146
+2% +$351K
GSK icon
59
GSK
GSK
$107B
$22.6M 0.33%
337,991
+13,973
+4% +$946K
DOX icon
60
Amdocs
DOX
$6.03B
$22.5M 0.33%
485,508
+88,224
+22% +$4.16M
DCM
61
DELISTED
NTT DOCOMO, Inc.
DCM
$22.2M 0.32%
1,301,112
+123,027
+10% +$2M
CHT icon
62
Chunghwa Telecom
CHT
$33.5B
$22.2M 0.32%
691,735
+70,154
+11% +$2.21M
TD icon
63
Toronto Dominion Bank
TD
$193B
$22.1M 0.32%
428,983
+47,520
+12% +$2.31M
BA icon
64
Boeing
BA
$169B
$22M 0.32%
172,822
+3,717
+2% +$485K
ABBV icon
65
AbbVie
ABBV
$465B
$21.1M 0.31%
374,090
+8,596
+2% +$451K
NTT
66
DELISTED
Nippon Telegraph & Telephone
NTT
$21M 0.31%
673,649
+86,316
+15% +$2.47M
MDT icon
67
Medtronic
MDT
$112B
$20.9M 0.3%
327,723
+48,929
+18% +$2.97M
CL icon
68
Colgate-Palmolive
CL
$74.8B
$20.8M 0.3%
304,994
+5,756
+2% +$386K
BTI icon
69
British American Tobacco
BTI
$136B
$20.2M 0.29%
339,048
+41,192
+14% +$2.41M
META icon
70
Meta Platforms (Facebook)
META
$1.49T
$20.1M 0.29%
298,730
+14,831
+5% +$912K
BNS icon
71
Scotiabank
BNS
$105B
$19.8M 0.29%
316,991
+49,043
+18% +$2.83M
TFCFA
72
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$19.7M 0.29%
560,278
+22,826
+4% +$776K
BIIB icon
73
Biogen
BIIB
$30.9B
$19.2M 0.28%
60,814
+935
+2% +$281K
MA icon
74
Mastercard
MA
$498B
$19.1M 0.28%
260,043
-2,001
-0.8% -$149K
NGG icon
75
National Grid
NGG
$79.3B
$18.9M 0.27%
263,150
+43,542
+20% +$3.01M

Similar funds

Aperio Group's Q2 2014 Portfolio in Review

As of Q2 2014, Aperio Group held 2,170 positions worth $6.89B, down 3.2% from $7.11B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Aperio Group withdrew a net $560M in Q2 2014, closing 437 positions and reducing 460 holdings. Its most notable exit was BASF AKTIENGESELLT ADS(RP1 ORD, an estimated $19M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Aperio Group opened a new position in Brookfield Property Partners L.P. Limited Partnership Units worth $2.28M.

  • Aperio Group's largest Q2 2014 buy was Brookfield Property Partners L.P. Limited Partnership Units: 109,335 shares worth $2.28M.
  • Aperio Group added most to Apple in Q2 2014, an estimated $7.72M increase.
  • Aperio Group's biggest Q2 2014 reduction was ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS, cutting an estimated $15.8M.
  • Aperio Group fully exited BASF AKTIENGESELLT ADS(RP1 ORD in Q2 2014, selling an estimated $19M.
  • Aperio Group's ten largest holdings make up 12% of its $6.89B portfolio in Q2 2014.
  • Aperio Group opened 136 new positions and closed 437 in Q2 2014.
  • Aperio Group's portfolio value fell 3.2% quarter-over-quarter to $6.89B.

Based on Aperio Group's 13F filing for Q2 2014, filed 23 Jul 2014.